nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefixime—SLC22A5—Dactinomycin—kidney cancer	0.403	1	CbGbCtD
Cefixime—SLC22A5—Temsirolimus—Everolimus—kidney cancer	0.0148	1	CbGdCrCtD
Cefixime—SLC15A1—nephron tubule—kidney cancer	0.00214	0.134	CbGeAlD
Cefixime—SLC15A1—renal system—kidney cancer	0.00194	0.121	CbGeAlD
Cefixime—SLC15A1—kidney—kidney cancer	0.00188	0.117	CbGeAlD
Cefixime—Convulsion—Everolimus—kidney cancer	0.00146	0.00257	CcSEcCtD
Cefixime—Erythema multiforme—Dactinomycin—kidney cancer	0.00144	0.00255	CcSEcCtD
Cefixime—Stevens-Johnson syndrome—Gemcitabine—kidney cancer	0.00143	0.00252	CcSEcCtD
Cefixime—Haemolytic anaemia—Capecitabine—kidney cancer	0.00142	0.00251	CcSEcCtD
Cefixime—Gastrointestinal pain—Pazopanib—kidney cancer	0.00142	0.00251	CcSEcCtD
Cefixime—Renal failure—Gemcitabine—kidney cancer	0.00142	0.0025	CcSEcCtD
Cefixime—Toxic epidermal necrolysis—Paclitaxel—kidney cancer	0.00141	0.00249	CcSEcCtD
Cefixime—Renal failure acute—Capecitabine—kidney cancer	0.00139	0.00246	CcSEcCtD
Cefixime—Flatulence—Sunitinib—kidney cancer	0.00138	0.00244	CcSEcCtD
Cefixime—Abdominal pain—Pazopanib—kidney cancer	0.00137	0.00243	CcSEcCtD
Cefixime—Hypersensitivity—Temsirolimus—kidney cancer	0.00136	0.0024	CcSEcCtD
Cefixime—Renal impairment—Capecitabine—kidney cancer	0.00135	0.00239	CcSEcCtD
Cefixime—Shock—Everolimus—kidney cancer	0.00135	0.00238	CcSEcCtD
Cefixime—Thrombocytopenia—Vinblastine—kidney cancer	0.00135	0.00238	CcSEcCtD
Cefixime—Agranulocytosis—Gemcitabine—kidney cancer	0.00135	0.00238	CcSEcCtD
Cefixime—Dermatitis bullous—Capecitabine—kidney cancer	0.00135	0.00238	CcSEcCtD
Cefixime—Thrombocytopenia—Everolimus—kidney cancer	0.00134	0.00237	CcSEcCtD
Cefixime—SLC15A2—nephron tubule—kidney cancer	0.00134	0.0835	CbGeAlD
Cefixime—Angioedema—Sorafenib—kidney cancer	0.00133	0.00236	CcSEcCtD
Cefixime—Leukopenia—Sorafenib—kidney cancer	0.00131	0.00231	CcSEcCtD
Cefixime—Pruritus—Temsirolimus—kidney cancer	0.00131	0.0023	CcSEcCtD
Cefixime—Shock—Erlotinib—kidney cancer	0.0013	0.0023	CcSEcCtD
Cefixime—Haemoglobin—Gemcitabine—kidney cancer	0.0013	0.0023	CcSEcCtD
Cefixime—Thrombocytopenia—Erlotinib—kidney cancer	0.0013	0.00229	CcSEcCtD
Cefixime—Haemorrhage—Gemcitabine—kidney cancer	0.00129	0.00229	CcSEcCtD
Cefixime—Pancytopenia—Paclitaxel—kidney cancer	0.00129	0.00227	CcSEcCtD
Cefixime—Angioedema—Sunitinib—kidney cancer	0.00128	0.00227	CcSEcCtD
Cefixime—Neutropenia—Paclitaxel—kidney cancer	0.00127	0.00224	CcSEcCtD
Cefixime—Diarrhoea—Temsirolimus—kidney cancer	0.00126	0.00223	CcSEcCtD
Cefixime—Leukopenia—Sunitinib—kidney cancer	0.00126	0.00222	CcSEcCtD
Cefixime—Hyperbilirubinaemia—Doxorubicin—kidney cancer	0.00126	0.00222	CcSEcCtD
Cefixime—Face oedema—Capecitabine—kidney cancer	0.00124	0.00219	CcSEcCtD
Cefixime—Pruritus—Pazopanib—kidney cancer	0.00123	0.00217	CcSEcCtD
Cefixime—Erythema multiforme—Gemcitabine—kidney cancer	0.00122	0.00216	CcSEcCtD
Cefixime—Dizziness—Temsirolimus—kidney cancer	0.00122	0.00215	CcSEcCtD
Cefixime—Convulsion—Sunitinib—kidney cancer	0.00122	0.00215	CcSEcCtD
Cefixime—SLC15A2—renal system—kidney cancer	0.00121	0.0759	CbGeAlD
Cefixime—Dyspepsia—Everolimus—kidney cancer	0.00121	0.00213	CcSEcCtD
Cefixime—Blood bilirubin increased—Doxorubicin—kidney cancer	0.00121	0.00213	CcSEcCtD
Cefixime—Stevens-Johnson syndrome—Paclitaxel—kidney cancer	0.0012	0.00211	CcSEcCtD
Cefixime—Anaphylactic shock—Sorafenib—kidney cancer	0.00119	0.0021	CcSEcCtD
Cefixime—Leukopenia—Dactinomycin—kidney cancer	0.00119	0.0021	CcSEcCtD
Cefixime—Diarrhoea—Pazopanib—kidney cancer	0.00119	0.0021	CcSEcCtD
Cefixime—Renal failure—Paclitaxel—kidney cancer	0.00119	0.0021	CcSEcCtD
Cefixime—SLC15A2—kidney—kidney cancer	0.00117	0.0734	CbGeAlD
Cefixime—Urinary tract infection—Paclitaxel—kidney cancer	0.00117	0.00207	CcSEcCtD
Cefixime—Vomiting—Temsirolimus—kidney cancer	0.00117	0.00207	CcSEcCtD
Cefixime—Shock—Sorafenib—kidney cancer	0.00117	0.00207	CcSEcCtD
Cefixime—Thrombocytopenia—Sorafenib—kidney cancer	0.00117	0.00206	CcSEcCtD
Cefixime—Dyspepsia—Erlotinib—kidney cancer	0.00117	0.00206	CcSEcCtD
Cefixime—Rash—Temsirolimus—kidney cancer	0.00116	0.00205	CcSEcCtD
Cefixime—Dermatitis—Temsirolimus—kidney cancer	0.00116	0.00205	CcSEcCtD
Cefixime—SLC22A5—nephron tubule—kidney cancer	0.00116	0.0726	CbGeAlD
Cefixime—Toxic epidermal necrolysis—Capecitabine—kidney cancer	0.00116	0.00204	CcSEcCtD
Cefixime—Headache—Temsirolimus—kidney cancer	0.00116	0.00204	CcSEcCtD
Cefixime—Dizziness—Pazopanib—kidney cancer	0.00115	0.00203	CcSEcCtD
Cefixime—SLC15A2—cortex of kidney—kidney cancer	0.00114	0.0715	CbGeAlD
Cefixime—Vaginal inflammation—Doxorubicin—kidney cancer	0.00114	0.00202	CcSEcCtD
Cefixime—Shock—Sunitinib—kidney cancer	0.00113	0.00199	CcSEcCtD
Cefixime—Gastrointestinal pain—Vinblastine—kidney cancer	0.00113	0.00199	CcSEcCtD
Cefixime—Thrombocytopenia—Sunitinib—kidney cancer	0.00112	0.00198	CcSEcCtD
Cefixime—Gastrointestinal pain—Everolimus—kidney cancer	0.00112	0.00198	CcSEcCtD
Cefixime—Vomiting—Pazopanib—kidney cancer	0.00111	0.00195	CcSEcCtD
Cefixime—Colitis—Doxorubicin—kidney cancer	0.0011	0.00194	CcSEcCtD
Cefixime—Rash—Pazopanib—kidney cancer	0.0011	0.00194	CcSEcCtD
Cefixime—Nausea—Temsirolimus—kidney cancer	0.0011	0.00194	CcSEcCtD
Cefixime—Dermatitis—Pazopanib—kidney cancer	0.0011	0.00193	CcSEcCtD
Cefixime—Candida infection—Doxorubicin—kidney cancer	0.00109	0.00192	CcSEcCtD
Cefixime—Haemoglobin—Paclitaxel—kidney cancer	0.00109	0.00192	CcSEcCtD
Cefixime—Abdominal pain—Vinblastine—kidney cancer	0.00109	0.00192	CcSEcCtD
Cefixime—Headache—Pazopanib—kidney cancer	0.00109	0.00192	CcSEcCtD
Cefixime—Abdominal pain—Everolimus—kidney cancer	0.00109	0.00192	CcSEcCtD
Cefixime—Body temperature increased—Everolimus—kidney cancer	0.00109	0.00192	CcSEcCtD
Cefixime—Haemorrhage—Paclitaxel—kidney cancer	0.00108	0.00191	CcSEcCtD
Cefixime—Gastrointestinal pain—Erlotinib—kidney cancer	0.00108	0.00191	CcSEcCtD
Cefixime—Vaginal infection—Doxorubicin—kidney cancer	0.00108	0.0019	CcSEcCtD
Cefixime—Aplastic anaemia—Doxorubicin—kidney cancer	0.00107	0.00189	CcSEcCtD
Cefixime—Leukopenia—Vincristine—kidney cancer	0.00106	0.00188	CcSEcCtD
Cefixime—Thrombocytopenia—Dactinomycin—kidney cancer	0.00106	0.00188	CcSEcCtD
Cefixime—SLC22A5—renal system—kidney cancer	0.00106	0.066	CbGeAlD
Cefixime—Pancytopenia—Capecitabine—kidney cancer	0.00106	0.00186	CcSEcCtD
Cefixime—Dyspepsia—Sorafenib—kidney cancer	0.00105	0.00185	CcSEcCtD
Cefixime—Abdominal pain—Erlotinib—kidney cancer	0.00105	0.00185	CcSEcCtD
Cefixime—Body temperature increased—Erlotinib—kidney cancer	0.00105	0.00185	CcSEcCtD
Cefixime—Neutropenia—Capecitabine—kidney cancer	0.00104	0.00183	CcSEcCtD
Cefixime—Nausea—Pazopanib—kidney cancer	0.00103	0.00182	CcSEcCtD
Cefixime—Convulsion—Vincristine—kidney cancer	0.00103	0.00182	CcSEcCtD
Cefixime—Erythema multiforme—Paclitaxel—kidney cancer	0.00103	0.00181	CcSEcCtD
Cefixime—SLC22A5—kidney—kidney cancer	0.00102	0.0638	CbGeAlD
Cefixime—Hypersensitivity—Vinblastine—kidney cancer	0.00102	0.00179	CcSEcCtD
Cefixime—Hypersensitivity—Everolimus—kidney cancer	0.00101	0.00179	CcSEcCtD
Cefixime—Dyspepsia—Sunitinib—kidney cancer	0.00101	0.00178	CcSEcCtD
Cefixime—Leukopenia—Gemcitabine—kidney cancer	0.00101	0.00178	CcSEcCtD
Cefixime—SLC22A5—cortex of kidney—kidney cancer	0.000995	0.0621	CbGeAlD
Cefixime—Stevens-Johnson syndrome—Capecitabine—kidney cancer	0.000983	0.00173	CcSEcCtD
Cefixime—Gastrointestinal pain—Sorafenib—kidney cancer	0.000974	0.00172	CcSEcCtD
Cefixime—Renal failure—Capecitabine—kidney cancer	0.000974	0.00172	CcSEcCtD
Cefixime—Pruritus—Everolimus—kidney cancer	0.000971	0.00171	CcSEcCtD
Cefixime—Anaphylactic shock—Vincristine—kidney cancer	0.00097	0.00171	CcSEcCtD
Cefixime—Jaundice—Capecitabine—kidney cancer	0.000966	0.00171	CcSEcCtD
Cefixime—Urinary tract infection—Capecitabine—kidney cancer	0.000963	0.0017	CcSEcCtD
Cefixime—Thrombocytopenia—Vincristine—kidney cancer	0.00095	0.00168	CcSEcCtD
Cefixime—Hepatic function abnormal—Doxorubicin—kidney cancer	0.000949	0.00167	CcSEcCtD
Cefixime—Urticaria—Sorafenib—kidney cancer	0.000947	0.00167	CcSEcCtD
Cefixime—SLC22A5—cardiac atrium—kidney cancer	0.000946	0.0591	CbGeAlD
Cefixime—Diarrhoea—Vinblastine—kidney cancer	0.000943	0.00166	CcSEcCtD
Cefixime—Body temperature increased—Sorafenib—kidney cancer	0.000942	0.00166	CcSEcCtD
Cefixime—Abdominal pain—Sorafenib—kidney cancer	0.000942	0.00166	CcSEcCtD
Cefixime—Diarrhoea—Everolimus—kidney cancer	0.000939	0.00166	CcSEcCtD
Cefixime—Gastrointestinal pain—Sunitinib—kidney cancer	0.000938	0.00166	CcSEcCtD
Cefixime—Pruritus—Erlotinib—kidney cancer	0.000937	0.00165	CcSEcCtD
Cefixime—Flatulence—Paclitaxel—kidney cancer	0.00093	0.00164	CcSEcCtD
Cefixime—Agranulocytosis—Capecitabine—kidney cancer	0.000925	0.00163	CcSEcCtD
Cefixime—Anaphylactic shock—Gemcitabine—kidney cancer	0.00092	0.00162	CcSEcCtD
Cefixime—Dizziness—Vinblastine—kidney cancer	0.000911	0.00161	CcSEcCtD
Cefixime—Dizziness—Everolimus—kidney cancer	0.000908	0.0016	CcSEcCtD
Cefixime—Abdominal pain—Sunitinib—kidney cancer	0.000906	0.0016	CcSEcCtD
Cefixime—Body temperature increased—Sunitinib—kidney cancer	0.000906	0.0016	CcSEcCtD
Cefixime—Diarrhoea—Erlotinib—kidney cancer	0.000906	0.0016	CcSEcCtD
Cefixime—Thrombocytopenia—Gemcitabine—kidney cancer	0.000901	0.00159	CcSEcCtD
Cefixime—Renal failure acute—Doxorubicin—kidney cancer	0.000898	0.00159	CcSEcCtD
Cefixime—Haemoglobin—Capecitabine—kidney cancer	0.000894	0.00158	CcSEcCtD
Cefixime—Haemorrhage—Capecitabine—kidney cancer	0.00089	0.00157	CcSEcCtD
Cefixime—Hepatitis—Capecitabine—kidney cancer	0.00089	0.00157	CcSEcCtD
Cefixime—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000888	0.00157	CcSEcCtD
Cefixime—Hypersensitivity—Sorafenib—kidney cancer	0.000878	0.00155	CcSEcCtD
Cefixime—Vomiting—Vinblastine—kidney cancer	0.000876	0.00155	CcSEcCtD
Cefixime—Dizziness—Erlotinib—kidney cancer	0.000876	0.00155	CcSEcCtD
Cefixime—Vomiting—Everolimus—kidney cancer	0.000873	0.00154	CcSEcCtD
Cefixime—Renal impairment—Doxorubicin—kidney cancer	0.000871	0.00154	CcSEcCtD
Cefixime—Dermatitis bullous—Doxorubicin—kidney cancer	0.000867	0.00153	CcSEcCtD
Cefixime—Rash—Everolimus—kidney cancer	0.000866	0.00153	CcSEcCtD
Cefixime—Dermatitis—Everolimus—kidney cancer	0.000865	0.00153	CcSEcCtD
Cefixime—Headache—Vinblastine—kidney cancer	0.000863	0.00152	CcSEcCtD
Cefixime—Angioedema—Paclitaxel—kidney cancer	0.000862	0.00152	CcSEcCtD
Cefixime—Headache—Everolimus—kidney cancer	0.00086	0.00152	CcSEcCtD
Cefixime—Body temperature increased—Dactinomycin—kidney cancer	0.000858	0.00151	CcSEcCtD
Cefixime—Abdominal pain—Dactinomycin—kidney cancer	0.000858	0.00151	CcSEcCtD
Cefixime—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.000857	0.00151	CcSEcCtD
Cefixime—Leukopenia—Paclitaxel—kidney cancer	0.000845	0.00149	CcSEcCtD
Cefixime—Hypersensitivity—Sunitinib—kidney cancer	0.000845	0.00149	CcSEcCtD
Cefixime—Pruritus—Sorafenib—kidney cancer	0.000843	0.00149	CcSEcCtD
Cefixime—Vomiting—Erlotinib—kidney cancer	0.000842	0.00149	CcSEcCtD
Cefixime—Erythema multiforme—Capecitabine—kidney cancer	0.000841	0.00149	CcSEcCtD
Cefixime—Rash—Erlotinib—kidney cancer	0.000835	0.00147	CcSEcCtD
Cefixime—Dermatitis—Erlotinib—kidney cancer	0.000834	0.00147	CcSEcCtD
Cefixime—Headache—Erlotinib—kidney cancer	0.00083	0.00146	CcSEcCtD
Cefixime—Nausea—Vinblastine—kidney cancer	0.000819	0.00144	CcSEcCtD
Cefixime—Convulsion—Paclitaxel—kidney cancer	0.000818	0.00144	CcSEcCtD
Cefixime—Nausea—Everolimus—kidney cancer	0.000815	0.00144	CcSEcCtD
Cefixime—Diarrhoea—Sorafenib—kidney cancer	0.000815	0.00144	CcSEcCtD
Cefixime—Pruritus—Sunitinib—kidney cancer	0.000811	0.00143	CcSEcCtD
Cefixime—Face oedema—Doxorubicin—kidney cancer	0.0008	0.00141	CcSEcCtD
Cefixime—Hypersensitivity—Dactinomycin—kidney cancer	0.0008	0.00141	CcSEcCtD
Cefixime—Gastrointestinal pain—Vincristine—kidney cancer	0.000793	0.0014	CcSEcCtD
Cefixime—Dizziness—Sorafenib—kidney cancer	0.000788	0.00139	CcSEcCtD
Cefixime—Nausea—Erlotinib—kidney cancer	0.000787	0.00139	CcSEcCtD
Cefixime—Diarrhoea—Sunitinib—kidney cancer	0.000785	0.00138	CcSEcCtD
Cefixime—Anaphylactic shock—Paclitaxel—kidney cancer	0.00077	0.00136	CcSEcCtD
Cefixime—Body temperature increased—Vincristine—kidney cancer	0.000767	0.00135	CcSEcCtD
Cefixime—Abdominal pain—Vincristine—kidney cancer	0.000767	0.00135	CcSEcCtD
Cefixime—Flatulence—Capecitabine—kidney cancer	0.000763	0.00135	CcSEcCtD
Cefixime—Dizziness—Sunitinib—kidney cancer	0.000758	0.00134	CcSEcCtD
Cefixime—Shock—Paclitaxel—kidney cancer	0.000758	0.00134	CcSEcCtD
Cefixime—Vomiting—Sorafenib—kidney cancer	0.000758	0.00134	CcSEcCtD
Cefixime—Thrombocytopenia—Paclitaxel—kidney cancer	0.000754	0.00133	CcSEcCtD
Cefixime—Rash—Sorafenib—kidney cancer	0.000751	0.00133	CcSEcCtD
Cefixime—Dermatitis—Sorafenib—kidney cancer	0.000751	0.00133	CcSEcCtD
Cefixime—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000747	0.00132	CcSEcCtD
Cefixime—Headache—Sorafenib—kidney cancer	0.000746	0.00132	CcSEcCtD
Cefixime—Diarrhoea—Dactinomycin—kidney cancer	0.000743	0.00131	CcSEcCtD
Cefixime—Vomiting—Sunitinib—kidney cancer	0.000729	0.00129	CcSEcCtD
Cefixime—Body temperature increased—Gemcitabine—kidney cancer	0.000727	0.00128	CcSEcCtD
Cefixime—Rash—Sunitinib—kidney cancer	0.000723	0.00128	CcSEcCtD
Cefixime—Dermatitis—Sunitinib—kidney cancer	0.000722	0.00128	CcSEcCtD
Cefixime—Headache—Sunitinib—kidney cancer	0.000718	0.00127	CcSEcCtD
Cefixime—Hypersensitivity—Vincristine—kidney cancer	0.000715	0.00126	CcSEcCtD
Cefixime—Eosinophilia—Doxorubicin—kidney cancer	0.000709	0.00125	CcSEcCtD
Cefixime—Nausea—Sorafenib—kidney cancer	0.000708	0.00125	CcSEcCtD
Cefixime—Leukopenia—Capecitabine—kidney cancer	0.000693	0.00122	CcSEcCtD
Cefixime—Vomiting—Dactinomycin—kidney cancer	0.00069	0.00122	CcSEcCtD
Cefixime—Rash—Dactinomycin—kidney cancer	0.000684	0.00121	CcSEcCtD
Cefixime—Nausea—Sunitinib—kidney cancer	0.000681	0.0012	CcSEcCtD
Cefixime—Pancytopenia—Doxorubicin—kidney cancer	0.00068	0.0012	CcSEcCtD
Cefixime—Dyspepsia—Paclitaxel—kidney cancer	0.000678	0.0012	CcSEcCtD
Cefixime—Neutropenia—Doxorubicin—kidney cancer	0.00067	0.00118	CcSEcCtD
Cefixime—Diarrhoea—Vincristine—kidney cancer	0.000664	0.00117	CcSEcCtD
Cefixime—Pruritus—Gemcitabine—kidney cancer	0.000651	0.00115	CcSEcCtD
Cefixime—Nausea—Dactinomycin—kidney cancer	0.000645	0.00114	CcSEcCtD
Cefixime—Dizziness—Vincristine—kidney cancer	0.000641	0.00113	CcSEcCtD
Cefixime—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000633	0.00112	CcSEcCtD
Cefixime—Gastrointestinal pain—Paclitaxel—kidney cancer	0.00063	0.00111	CcSEcCtD
Cefixime—Diarrhoea—Gemcitabine—kidney cancer	0.000629	0.00111	CcSEcCtD
Cefixime—Renal failure—Doxorubicin—kidney cancer	0.000628	0.00111	CcSEcCtD
Cefixime—Jaundice—Doxorubicin—kidney cancer	0.000623	0.0011	CcSEcCtD
Cefixime—Shock—Capecitabine—kidney cancer	0.000622	0.0011	CcSEcCtD
Cefixime—Urinary tract infection—Doxorubicin—kidney cancer	0.000621	0.0011	CcSEcCtD
Cefixime—Thrombocytopenia—Capecitabine—kidney cancer	0.000619	0.00109	CcSEcCtD
Cefixime—Vomiting—Vincristine—kidney cancer	0.000617	0.00109	CcSEcCtD
Cefixime—Urticaria—Paclitaxel—kidney cancer	0.000612	0.00108	CcSEcCtD
Cefixime—Rash—Vincristine—kidney cancer	0.000611	0.00108	CcSEcCtD
Cefixime—Dermatitis—Vincristine—kidney cancer	0.000611	0.00108	CcSEcCtD
Cefixime—Body temperature increased—Paclitaxel—kidney cancer	0.000609	0.00107	CcSEcCtD
Cefixime—Abdominal pain—Paclitaxel—kidney cancer	0.000609	0.00107	CcSEcCtD
Cefixime—Headache—Vincristine—kidney cancer	0.000608	0.00107	CcSEcCtD
Cefixime—Agranulocytosis—Doxorubicin—kidney cancer	0.000596	0.00105	CcSEcCtD
Cefixime—Vomiting—Gemcitabine—kidney cancer	0.000585	0.00103	CcSEcCtD
Cefixime—Rash—Gemcitabine—kidney cancer	0.00058	0.00102	CcSEcCtD
Cefixime—Dermatitis—Gemcitabine—kidney cancer	0.00058	0.00102	CcSEcCtD
Cefixime—Haemoglobin—Doxorubicin—kidney cancer	0.000576	0.00102	CcSEcCtD
Cefixime—Headache—Gemcitabine—kidney cancer	0.000576	0.00102	CcSEcCtD
Cefixime—Nausea—Vincristine—kidney cancer	0.000576	0.00102	CcSEcCtD
Cefixime—Haemorrhage—Doxorubicin—kidney cancer	0.000574	0.00101	CcSEcCtD
Cefixime—Hepatitis—Doxorubicin—kidney cancer	0.000574	0.00101	CcSEcCtD
Cefixime—Hypersensitivity—Paclitaxel—kidney cancer	0.000568	0.001	CcSEcCtD
Cefixime—Dyspepsia—Capecitabine—kidney cancer	0.000556	0.000982	CcSEcCtD
Cefixime—Nausea—Gemcitabine—kidney cancer	0.000546	0.000965	CcSEcCtD
Cefixime—Pruritus—Paclitaxel—kidney cancer	0.000545	0.000962	CcSEcCtD
Cefixime—Erythema multiforme—Doxorubicin—kidney cancer	0.000542	0.000957	CcSEcCtD
Cefixime—Diarrhoea—Paclitaxel—kidney cancer	0.000527	0.00093	CcSEcCtD
Cefixime—Gastrointestinal pain—Capecitabine—kidney cancer	0.000517	0.000912	CcSEcCtD
Cefixime—Dizziness—Paclitaxel—kidney cancer	0.000509	0.000899	CcSEcCtD
Cefixime—Urticaria—Capecitabine—kidney cancer	0.000502	0.000886	CcSEcCtD
Cefixime—Abdominal pain—Capecitabine—kidney cancer	0.0005	0.000882	CcSEcCtD
Cefixime—Body temperature increased—Capecitabine—kidney cancer	0.0005	0.000882	CcSEcCtD
Cefixime—Flatulence—Doxorubicin—kidney cancer	0.000492	0.000868	CcSEcCtD
Cefixime—Vomiting—Paclitaxel—kidney cancer	0.00049	0.000865	CcSEcCtD
Cefixime—Rash—Paclitaxel—kidney cancer	0.000486	0.000857	CcSEcCtD
Cefixime—Dermatitis—Paclitaxel—kidney cancer	0.000485	0.000857	CcSEcCtD
Cefixime—Headache—Paclitaxel—kidney cancer	0.000483	0.000852	CcSEcCtD
Cefixime—Hypersensitivity—Capecitabine—kidney cancer	0.000466	0.000822	CcSEcCtD
Cefixime—Nausea—Paclitaxel—kidney cancer	0.000458	0.000808	CcSEcCtD
Cefixime—Pruritus—Capecitabine—kidney cancer	0.000447	0.000789	CcSEcCtD
Cefixime—Leukopenia—Doxorubicin—kidney cancer	0.000447	0.000789	CcSEcCtD
Cefixime—Convulsion—Doxorubicin—kidney cancer	0.000433	0.000764	CcSEcCtD
Cefixime—Diarrhoea—Capecitabine—kidney cancer	0.000433	0.000764	CcSEcCtD
Cefixime—Dizziness—Capecitabine—kidney cancer	0.000418	0.000738	CcSEcCtD
Cefixime—Anaphylactic shock—Doxorubicin—kidney cancer	0.000407	0.000719	CcSEcCtD
Cefixime—Vomiting—Capecitabine—kidney cancer	0.000402	0.00071	CcSEcCtD
Cefixime—Shock—Doxorubicin—kidney cancer	0.000401	0.000708	CcSEcCtD
Cefixime—Thrombocytopenia—Doxorubicin—kidney cancer	0.000399	0.000704	CcSEcCtD
Cefixime—Rash—Capecitabine—kidney cancer	0.000399	0.000704	CcSEcCtD
Cefixime—Dermatitis—Capecitabine—kidney cancer	0.000398	0.000703	CcSEcCtD
Cefixime—Headache—Capecitabine—kidney cancer	0.000396	0.000699	CcSEcCtD
Cefixime—Nausea—Capecitabine—kidney cancer	0.000375	0.000663	CcSEcCtD
Cefixime—Dyspepsia—Doxorubicin—kidney cancer	0.000359	0.000633	CcSEcCtD
Cefixime—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000333	0.000588	CcSEcCtD
Cefixime—Urticaria—Doxorubicin—kidney cancer	0.000324	0.000571	CcSEcCtD
Cefixime—Abdominal pain—Doxorubicin—kidney cancer	0.000322	0.000569	CcSEcCtD
Cefixime—Body temperature increased—Doxorubicin—kidney cancer	0.000322	0.000569	CcSEcCtD
Cefixime—Hypersensitivity—Doxorubicin—kidney cancer	0.0003	0.00053	CcSEcCtD
Cefixime—Pruritus—Doxorubicin—kidney cancer	0.000288	0.000509	CcSEcCtD
Cefixime—Diarrhoea—Doxorubicin—kidney cancer	0.000279	0.000492	CcSEcCtD
Cefixime—Dizziness—Doxorubicin—kidney cancer	0.000269	0.000476	CcSEcCtD
Cefixime—Vomiting—Doxorubicin—kidney cancer	0.000259	0.000457	CcSEcCtD
Cefixime—Rash—Doxorubicin—kidney cancer	0.000257	0.000454	CcSEcCtD
Cefixime—Dermatitis—Doxorubicin—kidney cancer	0.000257	0.000453	CcSEcCtD
Cefixime—Headache—Doxorubicin—kidney cancer	0.000255	0.000451	CcSEcCtD
Cefixime—Nausea—Doxorubicin—kidney cancer	0.000242	0.000427	CcSEcCtD
